(Q38880745)

7 September 2017

title

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets (English)

1 reference

7 September 2017

0 references

1 reference

1 reference

17

1 reference

7 September 2017

Federica Di Nicolantonio

18

Federica Di Nicolantonio

0 references

Marcella Mottolese

15

Marcella Mottolese

0 references

Giorgio Corti

Giorgio Corti

6

0 references

Mariangela Russo

Mariangela Russo

2

0 references

Emanuele Valtorta

Emanuele Valtorta

5

0 references

Claudio Isella

Claudio Isella

8

0 references

Marco Beccuti

Marco Beccuti

14

0 references

Enzo Medico

Enzo Medico

1

0 references

Andrea Sartore-Bianchi

Andrea Sartore-Bianchi

13

0 references

Silvio Marco Veronese

Silvio Veronese

11

0 references

Alberto Bardelli

Alberto Bardelli

19

0 references

Salvatore Siena

Salvatore Siena

12

0 references

Michela Buscarino

7

Michela Buscarino

1 reference

7 September 2017

16

Michael Linnebacher

1 reference

7 September 2017

Gabriele Picco

3

1 reference

7 September 2017

Carlotta Cancelliere

4

1 reference

7 September 2017

Simona Lamba

9

1 reference

7 September 2017

Barbara Martinoglio

10

1 reference

7 September 2017

Marcella Mottolese

15

1 reference

7 September 2017

publication date

30 April 2015

1 reference

7 September 2017

language of work or name

English

0 references

published in

Nature Communications

1 reference

7 September 2017

volume

6

1 reference

7 September 2017

page(s)

7002

1 reference

describes a project that uses

7 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Systematic identification of genomic markers of drug sensitivity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

TiGER: a database for tissue-specific gene expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Cancer cell lines for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Outlier kinase expression by RNA sequencing as targets for precision therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Functional viability profiles of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

TopHat: discovering splice junctions with RNA-Seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS8002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS8002

1 reference

Dimensions Publication ID

7 September 2017

0 references

1000896478

0 references

1 reference